Numab Therapeutics lands $110m Series C

Numab Therapeutics AG, a clinical stage biopharmaceutical company, has raised about $110 million in Series C financing.

Numab Therapeutics AG, a clinical stage biopharmaceutical company, has raised about $110 million in Series C financing. Novo Holdings and HBM Partners led the round.

Source: Press Release